Loading quotes...

Forecast

There is no analyst data available for this company.

News Go to news feed

Avingtrans secures £21m through placing new shares

Avingtrans raised around £21m by placing 3,309,000 new ordinary shares at 630 pence each; the issue was oversubscribed and attracted both existing and new institutional investors. Roger McDowell subscribed for shares worth about £800,000. The proceeds are intended to finance growth at Hayward Tyler, notably the expansion of manufacturing capacity in Michigan; the new shares will represent about 9.0% of the enlarged issued share capital on admission. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics

In 2026, Avingtrans has already paid €0.0232 in dividends. The last payout was in June.

Financials

In the last quarter, Avingtrans had revenue of €98.43m and net profit of €3.41m

(EUR)	May 2026	YoY
Revenue	98.43m	-
Gross profit	31.86m	-
Net profit	3.41m	-
EBITDA	10.54m	-

Fundamentals

Metric	Value
Market capitalization	€337.83m
Number of shares	36.93m
52-week high/low	€9.33 - €5.62
Dividend yield	0.63%
Dividends TTM	€0.0574
Beta	0.59
P/E ratio	38.64
PEG ratio	-3,480,054,257,513,565.00
P/B ratio	2.06
P/S ratio	1.73

Company profile

Avingtrans plc manufactures and sells engineered components, systems, and services to the energy, medical, and infrastructure industries worldwide. It operates in three segments: Energy-EPM, Energy-PSRE, and Medical-MII. The company designs, manufactures, integrates, and services electric motors and pumps, steam turbines, gas compressors, pressure vessels, blast doors, containers, and skidded systems. It also designs and manufactures equipment for the medical, science and research communities, including products for medical diagnostic equipment; high performance pressure, vacuum vessels, and composite materials for research organizations; and superconducting magnets and helium-free cryogenic systems for use in magnetic resonance imaging and nuclear magnetic resonance. The company was incorporated in 1985 and is based in Chatteris, the United Kingdom.